Myeloid Lymphoid Neoplasms with Fgfr1 Rearrangement

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-11-18
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203) [Phase 2]
Phase 2 study FIGHT-203 evaluating pemigatinib in myeloid/lymphoid neoplasms with FGFR1 rearrangement has completed and results have been po…